deltatrials
Completed OBSERVATIONAL NCT01722786

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA)

Prospective, Observational, Non-interventional Open-label Multicenter Registry Regarding the Management of Severe Bleeding and/or Urgent Interventions During Treatment With Direct Oral Anticoagulants or Vitamin K Antagonists

Sponsor: Cardioangiologisches Centrum Bethanien

Conditions Severe Bleeding Urgent Surgery
Updated 17 times since 2017 Last updated: Jul 14, 2020 Started: Apr 30, 2014 Primary completion: Jun 30, 2018 Completion: Jul 9, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Severe Bleeding and Urgent Surgery and is currently completed. Cardioangiologisches Centrum Bethanien leads this study, which shows 17 recorded versions since 2014 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Aug 2017 · 7 months · monthly snapshot~Aug 2017 – ~Mar 2018 · 7 months · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Sep 2019 · 8 months · monthly snapshot~Sep 2019 – ~May 2020 · 8 months · monthly snapshot~May 2020 – ~Aug 2020 · 3 months · monthly snapshot~Aug 2020 – ~Nov 2020 · 3 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Apr 2022 · 4 months · monthly snapshot~Apr 2022 – ~Mar 2023 · 11 months · monthly snapshot~Mar 2023 – ~Jul 2024 · 16 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 23 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Mar 2023 — Jul 2024 [monthly]

    Completed

  4. Apr 2022 — Mar 2023 [monthly]

    Completed

  5. Dec 2021 — Apr 2022 [monthly]

    Completed

▶ Show 12 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed

  2. Nov 2020 — Jan 2021 [monthly]

    Completed

  3. Aug 2020 — Nov 2020 [monthly]

    Completed

  4. May 2020 — Aug 2020 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  5. Sep 2019 — May 2020 [monthly]

    Active Not Recruiting

  6. Jan 2019 — Sep 2019 [monthly]

    Active Not Recruiting

  7. Jun 2018 — Jan 2019 [monthly]

    Active Not Recruiting

  8. May 2018 — Jun 2018 [monthly]

    Active Not Recruiting

  9. Apr 2018 — May 2018 [monthly]

    Active Not Recruiting

    Phase: NA → None

  10. Mar 2018 — Apr 2018 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  11. Aug 2017 — Mar 2018 [monthly]

    Recruiting NA

  12. Jan 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cardioangiologisches Centrum Bethanien
  • Goethe University
  • Johannes Gutenberg University Mainz
  • Ruhr University of Bochum
  • Städtisches Klinikum Dresden-Friedrichstadt
  • Technische Universität Dresden
  • University Hospital Dresden
  • University Hospital Greifswald
  • University Hospital Schleswig-Holstein
  • University Hospital, Aachen
  • Vivantes Netzwerk für Gesundheit GmbH
Data source: Cardioangiologisches Centrum Bethanien

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations